Search results
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Singapore Finance· 7 hours agoThe approval for the COPD...to Prostate Cancer Candidate From Partner: Merck and Finnish ...
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Benzinga via Yahoo Singapore Finance· 5 days agoOn Wednesday, the European Medicines Agency (EMA) approved Dupixent (dupilumab) as an add-on...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo Singapore Finance· 5 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
GuruFocus.com via Yahoo Singapore Finance· 6 days agoThe transaction was documented in an SEC Filing. Following this transaction, the insider now owns...
Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Singapore Finance· 6 days agoThe fact that multiple Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders offloaded a...